Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01708304 · ClinicalTrials.gov registry record · NA
Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
A NA study of Dementia and Alzheimers Disease, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 510
- Enrollment target
- 1
- Study location
NCT01708304 is a NA study of Dementia and Alzheimers Disease that has completed, run by University of Washington. The registered enrollment target is 510 participants, below the 7,720-participant average among 199 other Dementia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01708304, a NA study of Dementia and Alzheimers Disease, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 510 participants
- Enrollment target
- 1
- Study location
Study Summary
The University of Washington's Northwest Research Group on Aging is partnering with Area Agencies on Aging (AAA) in Washington and Oregon to complete this translational investigation of RDAD (Reducing Disabilities in Alzheimer's Disease). RDAD is an evidence-based program with demonstrated efficacy in helping older adults with dementia maintain physical function and remain physically and mentally healthy. This study asks two questions: 1) Can AAA partners successfully translate and implement RDAD, and 2) Is AAA implementation of RDAD effective in producing desired outcomes among agencies, providers, and older adults with dementia and their family members. This study is being conducted in Washington and Oregon states.
Conditions Studied
Interventions
- BEHAVIORAL RDAD
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 510 participants |
| Start Date | 2012-11 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01708304
The ClinicalTrials.gov registry entry for NCT01708304 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 510 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,720-participant average among 199 other Dementia trials with a reported enrollment target (93% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which RDAD is the first listed.
NCT01708304 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT01708304 about?
NCT01708304 is a clinical study titled "Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)". The University of Washington's Northwest Research Group on Aging is partnering with Area Agencies on Aging (AAA) in Washington and Oregon to complete this translational investigation of RDAD (Reducing Disabilities in Alzheimer's Disease). RDAD is an evidence-based program with demonstrated efficacy ...
What is the current status of trial NCT01708304?
This trial is currently completed. It is a NA study. The enrollment target is 510 participants. The study started on 2012-11. Estimated completion is 2017-06.
What conditions does trial NCT01708304 study?
This clinical trial studies the following conditions: Dementia, Alzheimers Disease, Cognitive Impairment, Memory Impairment.
What interventions are being tested in trial NCT01708304?
The interventions under investigation include: RDAD (BEHAVIORAL).
Who is sponsoring clinical trial NCT01708304?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01708304 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Caregiver Bootcamp
RECRUITING · NA
-
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
RECRUITING · NA
-
Effect of Cognitive Empathy Training on Dementia Caregivers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.